Device Trial Radar · NCT07126327
Peristeen Light Explorative Clinical Investigation
Last checked: Nov 19, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Nov 10, 2025
Primary completion
Sep 2, 2026
Study completion Sep 2, 2026
Sponsor
- Lead sponsor
- Coloplast A/SNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 17, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this exploratory clinical investigation is to understand the clinical benefits of Peristeen Light in adult patients with faecal incontinence, chronic constipation and/or time-consuming bowel management procedures. The primary objective is to evaluate changes in bowel-function when using Peristeen Light. Participants will use Peristeen Light for 12 weeks test period.
Conditions
- Faecal Incontinence
- Constipation - Functional
Interventions
Peristeen Light - trans anal irrigation systemDevice
Subjects naive to TAI will use Peristeen Light trans anal irrigation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Bowel function measured on a 10 cm Visual Analog Scale (VAS) at Baseline Visit (V1) and End of Clinical Investigation Visit (V7).Time frame: From enrollment to the end of treatment at week 12.
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Århus University Hospital
Aarhus, Gotland, Denmark
Montecatone Rehabillitation Institute S.p.A
Bologna, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.